Instituto Bernabeu: Clinical Trials

19 trials sponsored by Instituto Bernabeu, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 4 unknown, 2 recruiting, 2 terminated. 9 Phase 4, 4 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 49Completed 5, Unknown 2, Not yet recruiting 1, Terminated 1
Not applicable4Completed 2, Terminated 1, Unknown 1

Follow Instituto Bernabeu: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non-Invasive Preimplantation Genetic Screening for Aneuploidies and Clinical Outcomes in Egg Donation Patients
IVF
RecruitingInstituto Bernabeu1642026-02-262026-01-23
Follicular Flushing Using Double Lumen Needle Versus Direct Aspiration in Low Prognosis Patients According to the POSEIDON Criteria
follicular flushing, follicular aspiration - Low Ovarian Reserve, Poor Response to Ovulation Induction Poseidon Type IV
Not applicableCompletedInstituto Bernabeu402026-01-012026-04-14
TRAP Study: Testosterone for Androgen Receptor Polymorphism
Transdermal Gel in Sachet Dosage Form, No pretreatment - Fertility Disorders
Phase 4Not yet recruitingInstituto Bernabeu1002025-09-302025-05-09
Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.
Progesterone 200 MG, Ganirelix Acetate - IVF
Phase 4CompletedInstituto Bernabeu1502023-12-232026-03-27
Continuous Double Ovarian Stimulation.
Corifollitropin Alfa, Follitropin Alfa, Follitropin Alfa Biosimilar - Fertility Issues
Phase 4CompletedInstituto Bernabeu302022-11-172025-05-18
Impact of Endometrial Compaction on Reproductive Outcomes After Cryotransfer of Euploid Embryos in a Natural Cycle
Observational non intervention study - Infertility Due to Nonimplantation
RecruitingInstituto Bernabeu2062022-06-152024-10-03
Comparison of Triggers in Double Ovarian Stimulation (DuoStim).
Triptorelin acetate (a-GnRH), Ovitrelle® (hCG), Decapeptyl 0.1 mg® (a-GnRH) and Ovitrelle® (hCG) used together - IVF, LOW OVARIAN RESPONSE
Phase 4UnknownInstituto Bernabeu1652022-03-032022-04-11
Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer.
Vaginally administered progesterone - Luteal Phase Defect
CompletedInstituto Bernabeu3472021-03-032021-03-19
Interaction Between the Vaginal and Seminal Microbiome in Patients With an Altered Vaginal Microbiome Pattern Resistant to Treatment
Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome resistant to drug treatment, Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome not resistant to drug treatment - Fertility Disorders
UnknownInstituto Bernabeu202021-02-012021-08-30
The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors
Bacterial Vaginoses
CompletedPeter Humaidan262020-05-152021-02-09
Follicular Phase Stimulation vs. Luteal Phase Stimulation in Patients Diagnosed With Suboptimal Response
time of administration of Corifollitropin Alfa - Improving Ovarian Stimulation; Suboptimal Responders
Phase 4CompletedInstituto Bernabeu412020-01-172022-04-06
Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor
Time of administration of Corifollitropin Alfa - Ovarian Stimulation
Phase 4CompletedInstituto Bernabeu1802019-11-182021-05-19
Validation of a NICS Method Using the Culture Medium
Noninvasive chromosome screening - Chromosome Abnormality, Abnormality
CompletedInstituto Bernabeu502019-02-012020-08-10
Vaginal Microbiome Influence on the Results of Assisted Reproduction Techniques
Probiotic - Implantation Failure
Not applicableCompletedInstituto Bernabeu692017-06-012022-03-31
Random-start Ovarian Stimulation in Egg-donors (ROSE)
Random start ovarian stimulation, Gonadotrophins, GnRH antagonist - Infertility
Phase 4TerminatedInstituto Bernabeu152017-01-102019-08-19
Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial)
Follicular phase, Luteal phase - Reproductive Techniques, Assisted
Not applicableUnknownInstituto Bernabeu602015-12-012018-08-29
Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)
Urinary follicle-stimulating hormone, Recombinant follicle-stimulating hormone - Reproductive Techniques, Assisted
Phase 4UnknownInstituto Bernabeu1802015-12-012018-08-28
Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients
subcutaneous progesterone, vaginal progesterone - Infertility
Phase 4CompletedInstituto Bernabeu1202015-02-012017-03-03
Prospective Randomized Study to Evaluate the Effect of Embryonic Observation on the Gestation (PROdE)
Embryo observation - Placenta; Implantation
Not applicableTerminatedInstituto Bernabeu1932015-02-012021-06-23

Conditions studied

Infertility (3)  ·  Helping Behavior (2)  ·  Chromosome Aberrations (1)  ·  Congenital Abnormalities (1)  ·  Disease (1)  ·  Vaginosis, Bacterial (1)

Interventions

Urofollitropin (2)  ·  Chorionic Gonadotropin (1)  ·  Follicular Phase (1)  ·  Glycoprotein Hormones, alpha Subunit (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  Gonadotropins (1)  ·  LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1)  ·  Luteal Phase (1)  ·  Ovulation Induction (1)  ·  Probiotics (1)  ·  Progesterone (1)  ·  Triptorelin Pamoate (1)  ·  follicle stimulating hormone, human, with HCG C-terminal peptide (1)  ·  follitropin alfa (1)  ·  ganirelix (1)

Countries

Spain (19)

Top investigators

Joanquin Llacer, Ph (1)  ·  Jorge Ten Morro, Ph.D. (1)  ·  Juan C Castillo, Md. PhD. (1)  ·  Juan Carlos Castillo Farfan, MD, PhD (1)

Results publications

PMID 12748128, PMID 19684043, PMID 24161646, PMID 25296696, PMID 25311972, PMID 25444501, PMID 27567429, PMID 28993105, PMID 29040638, PMID 29963011, PMID 30609935, PMID 32033610, PMID 32208810, PMID 32338123, PMID 33340402, PMID 38204945, PMID 38577571, PMID 38983736

NIH funding

2015 (2)